Raman image probe molecule with photothermal conversion capability and preparation and preparation method thereof
By designing a small-molecule Raman imaging probe with thiophene-coupled benzobisthiadiazole as the parent nucleus, the problem of requiring a metal substrate material in existing Raman imaging probes has been solved, realizing Raman scattering and photothermal conversion without substrate enhancement, thus improving the precision and safety of tumor treatment.
Patent Information
- Application Number
- CN202511004602.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-21
- Publication Date
- 2025-11-04
AI Technical Summary
Existing Raman imaging probes require the preparation of metal substrate materials, which raises concerns about biosafety and difficulty in in vivo metabolism. Furthermore, it is difficult to achieve Raman scattering signals and photothermal conversion performance without substrate enhancement.
A class of small molecule organic compound Raman imaging probes was designed, using thiophene-coupled benzobisthiadiazole as the parent core, and synthesized through Stille and Suzuki reactions. It has characteristic peaks of Raman shifts of 894 cm-1 and 1264 cm-1, and can generate strong Raman scattering signals and perform photothermal conversion in the aggregated state.
It enables in vivo Raman spectroscopy imaging and photothermal therapy without the need for surface enhancement on a metal substrate, improving the precision and safety of treatment and possessing highly efficient photothermal conversion capabilities.